HONOLULU -- Motavizumab, a humanized monoclonal antibody to respiratory syncytial virus (RSV) reduced hospital admissions among American-Indian infants by 83% compared with placebo, in a phase III study, researchers reported here.
hospitalization ratesPAS: Motavizumab Cuts RSV Infection and Hospitalization RatesMedPage Today Infectious Disease Mon, 05/05/2008 - 12:24
Tags:
An efficient response in primary care would reduce the use of ho...EurekAlert! - Infectious and Emerging Diseases Thu, 03/06/2008 - 23:00
Hospitalization rates could be reduced in more than 50 percent of cases of diabetic ketoacidosis, digestive hemorrhage and chronic bronchitis.The study, carried out with 717 patients over 60, has found the main reasons for hospitalization among the older population, regular users of these facilities. |
